Open Access
Outcomes associated to the time to treatment with intravenous tenecteplase for acute ischaemic stroke: subgroup analysis of the TRACE-2 randomised controlled clinical trial
Shuya Li, Runqi Wangqin, Yuesong Pan, Aoming Jin, Hao Li, Lee H Schwamm, Marc Fisher, Bruce C V Campbell, Mark W Parsons, Ziran Wang, Hongguo Dai, Deyang Li, Runhui Li, Junhai Wang, David Wang, Yilong Wang, Xingquan Zhao, Zixiao Li, Huaguang Zheng, Yunyun Xiong, Xia Meng, Yongjun Wang
DOI: 10.1136/svn-2023-002694 Published 30 December 2024
Shuya Li
1
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
China National Clinical Research Center for Neurological Diseases, Beijing, China
3
Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Runqi Wangqin
4
Department of Neurology, Duke University Medical Center, Durham, NC, USA
Yuesong Pan
1
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
China National Clinical Research Center for Neurological Diseases, Beijing, China
3
Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Aoming Jin
1
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
China National Clinical Research Center for Neurological Diseases, Beijing, China
3
Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Hao Li
1
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
China National Clinical Research Center for Neurological Diseases, Beijing, China
3
Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Lee H Schwamm
5
Department of Neurology and Comprehensive Stroke Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Marc Fisher
6
Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
Bruce C V Campbell
7
Department of Medicine and Neurology, Melbourne Brain Centre at Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia
Mark W Parsons
8
Department of Neurology, Liverpool Hospital, University of New South Wales South Western Sydney Clinical School, Sydney, New South Wales, Australia
Ziran Wang
9
Department of Neurology, Linyi People's Hospital, Linyi, Shandong, China
Hongguo Dai
10
Department of Neurology, Linfen Central Hospital, Linfen, China
Deyang Li
11
Department of Neurology, Tengzhou Central People's Hospital, Tengzhou, Shandong, China
Runhui Li
12
Central Hospital Affiliated to Shenyang Medical College, Shenyang, China
Junhai Wang
13
Department of Neurology, General Hospital of DaTong Coal Mine Group, Datong, Shanxi, China
David Wang
14
Department of Neurology, Petznick Stroke Center, Barrow Neurological Institute, Phoenix, Arizona, USA
Yilong Wang
1
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
China National Clinical Research Center for Neurological Diseases, Beijing, China
3
Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Xingquan Zhao
1
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
China National Clinical Research Center for Neurological Diseases, Beijing, China
3
Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Zixiao Li
1
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
China National Clinical Research Center for Neurological Diseases, Beijing, China
3
Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Huaguang Zheng
1
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
China National Clinical Research Center for Neurological Diseases, Beijing, China
3
Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Yunyun Xiong
1
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
China National Clinical Research Center for Neurological Diseases, Beijing, China
3
Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Xia Meng
1
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
China National Clinical Research Center for Neurological Diseases, Beijing, China
3
Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Yongjun Wang
1
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
China National Clinical Research Center for Neurological Diseases, Beijing, China
3
Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

Submit a Response to This Article
No eLetters have been published for this article.
Outcomes associated to the time to treatment with intravenous tenecteplase for acute ischaemic stroke: subgroup analysis of the TRACE-2 randomised controlled clinical trial
Shuya Li, Runqi Wangqin, Yuesong Pan, Aoming Jin, Hao Li, Lee H Schwamm, Marc Fisher, Bruce C V Campbell, Mark W Parsons, Ziran Wang, Hongguo Dai, Deyang Li, Runhui Li, Junhai Wang, David Wang, Yilong Wang, Xingquan Zhao, Zixiao Li, Huaguang Zheng, Yunyun Xiong, Xia Meng, Yongjun Wang
Stroke and Vascular Neurology Dec 2024, 9 (6) 613-622; DOI: 10.1136/svn-2023-002694

Outcomes associated to the time to treatment with intravenous tenecteplase for acute ischaemic stroke: subgroup analysis of the TRACE-2 randomised controlled clinical trial
Shuya Li, Runqi Wangqin, Yuesong Pan, Aoming Jin, Hao Li, Lee H Schwamm, Marc Fisher, Bruce C V Campbell, Mark W Parsons, Ziran Wang, Hongguo Dai, Deyang Li, Runhui Li, Junhai Wang, David Wang, Yilong Wang, Xingquan Zhao, Zixiao Li, Huaguang Zheng, Yunyun Xiong, Xia Meng, Yongjun Wang
Stroke and Vascular Neurology Dec 2024, 9 (6) 613-622; DOI: 10.1136/svn-2023-002694
Outcomes associated to the time to treatment with intravenous tenecteplase for acute ischaemic stroke: subgroup analysis of the TRACE-2 randomised controlled clinical trial
Shuya Li, Runqi Wangqin, Yuesong Pan, Aoming Jin, Hao Li, Lee H Schwamm, Marc Fisher, Bruce C V Campbell, Mark W Parsons, Ziran Wang, Hongguo Dai, Deyang Li, Runhui Li, Junhai Wang, David Wang, Yilong Wang, Xingquan Zhao, Zixiao Li, Huaguang Zheng, Yunyun Xiong, Xia Meng, Yongjun Wang
Stroke and Vascular Neurology Dec 2024, 9 (6) 613-622; DOI: 10.1136/svn-2023-002694